uniQure N.V.(QURE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

QURE uniQure N.V.

休市中 07-18 16:00:00 EDT

14.99

-0.21

-1.38%

盘后15.01

+0.02+0.13%

19:28 EDT

最高15.52	最低14.60	成交量179.50万
今开15.36	昨收15.20	日振幅6.05%
总市值8.21亿	流通市值5.31亿	总股本5,475万
成交额2,697万	换手率5.07%	流通股本3,540万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"QURE","market":"US","secType":"STK","nameCN":"uniQure N.V.","latestPrice":14.99,"timestamp":1752868800000,"preClose":15.2,"halted":0,"volume":1795001,"hourTrading":{"tag":"盘后","latestPrice":15.01,"preClose":14.99,"latestTime":"19:28 EDT","volume":138730,"amount":2077538.8898,"timestamp":1752881336280},"delay":0,"floatShares":35397700,"shares":54748496,"eps":-4.366288,"marketStatus":"休市中","change":-0.21,"latestTime":"07-18 16:00:00 EDT","open":15.36,"high":15.52,"low":14.6,"amount":26966109.752894003,"amplitude":0.060526,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.366288,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1391576400000,"exchange":"NASDAQ","adjPreClose":15.2,"preHourTrading":{"tag":"盘前","latestPrice":15.41,"preClose":15.2,"latestTime":"09:29 EDT","volume":422,"amount":6552.439154000001,"timestamp":1752845399910},"postHourTrading":{"tag":"盘后","latestPrice":15.01,"preClose":14.99,"latestTime":"19:28 EDT","volume":138730,"amount":2077538.8898,"timestamp":1752881336280},"volumeRatio":1.4564252414484358,"impliedVol":1.4563,"impliedVolPercentile":0.968},"requestUrl":"/m/hq/s/QURE","defaultTab":"news","newsList":[{"id":"2552480469","title":"Uniqure N.V.盘中异动 早盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552480469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552480469?lang=zh_cn&edition=full","pubTime":"2025-07-17 23:24","pubTimestamp":1752765874,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日23时24分，Uniqure N.V.股票出现波动，股价急速拉升5.20%。截至发稿，该股报15.17美元/股，成交量48.8245万股，换手率0.89%，振幅4.79%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.22%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717232434954653dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717232434954653dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2548157338","title":"Uniqure N.V.盘中异动 急速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548157338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548157338?lang=zh_cn&edition=full","pubTime":"2025-07-02 22:39","pubTimestamp":1751467185,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日22时39分，Uniqure N.V.股票出现异动，股价快速拉升5.04%。截至发稿，该股报14.70美元/股，成交量20.6607万股，换手率0.38%，振幅4.57%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.74%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507022239459797671d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507022239459797671d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2546725284","title":"Uniqure N.V.盘中异动 下午盘股价大跌5.06%报13.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546725284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546725284?lang=zh_cn&edition=full","pubTime":"2025-06-28 02:43","pubTimestamp":1751049805,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日02时43分，Uniqure N.V.股票出现波动，股价急速下跌5.06%。截至发稿，该股报13.51美元/股，成交量42.9081万股，换手率0.78%，振幅4.85%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.68%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628024325a4c1bc13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628024325a4c1bc13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2545317459","title":"Uniqure N.V.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545317459","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545317459?lang=zh_cn&edition=full","pubTime":"2025-06-21 01:09","pubTimestamp":1750439351,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日01时09分，Uniqure N.V.股票出现波动，股价大幅下挫5.03%。截至发稿，该股报14.34美元/股，成交量57.8722万股，换手率1.06%，振幅4.90%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.56%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506210109119524fea7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506210109119524fea7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2543345634","title":"Uniqure N.V.盘中异动 急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543345634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543345634?lang=zh_cn&edition=full","pubTime":"2025-06-14 02:20","pubTimestamp":1749838859,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日02时20分，Uniqure N.V.股票出现波动，股价急速下跌5.00%。截至发稿，该股报15.19美元/股，成交量30.914万股，换手率0.56%，振幅5.00%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.57%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614022059a7080919&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614022059a7080919&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2541867279","title":"Uniqure N.V.盘中异动 股价大涨5.06%报17.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541867279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541867279?lang=zh_cn&edition=full","pubTime":"2025-06-07 02:26","pubTimestamp":1749234410,"startTime":"0","endTime":"0","summary":"北京时间2025年06月07日02时26分，Uniqure N.V.股票出现波动，股价快速上涨5.06%。截至发稿，该股报17.45美元/股，成交量103.73万股，换手率1.89%，振幅3.31%。机构评级方面，在所有14家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.51%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506070226509511a592&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506070226509511a592&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2541107176","title":"Uniqure N.V.盘中异动 股价大涨5.28%报15.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541107176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541107176?lang=zh_cn&edition=full","pubTime":"2025-06-05 23:20","pubTimestamp":1749136855,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日23时20分，Uniqure N.V.股票出现波动，股价大幅拉升5.28%。截至发稿，该股报15.75美元/股，成交量22.1782万股，换手率0.41%，振幅6.28%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.37%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605232055a49b9cb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605232055a49b9cb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2540796846","title":"Uniqure N.V.盘中异动 大幅拉升5.32%报15.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540796846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540796846?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:34","pubTimestamp":1748871263,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时34分，Uniqure N.V.股票出现波动，股价大幅拉升5.32%。截至发稿，该股报15.24美元/股，成交量8.8248万股，换手率0.16%，振幅4.08%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.63%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213423976e813f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213423976e813f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2539273845","title":"Uniqure N.V.盘中异动 早盘股价大跌5.00%报14.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539273845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539273845?lang=zh_cn&edition=full","pubTime":"2025-05-30 22:01","pubTimestamp":1748613668,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日22时01分，Uniqure N.V.股票出现波动，股价快速下跌5.00%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为4.33%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。消息层面，截至22时01分，《神经科医生看好亨廷顿病将上市疗法 瑞银力挺uniQure潜力》资讯为影响Uniqure N.V.的重要信息。瑞银对 PTC Therapeutics Inc和 uniQure NV均持乐观态度，给予买入评级。该行强调，亨廷顿病领域患者认知度高、治疗意愿强烈，对PTC和uniQure而言均存在巨大机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530220108950854e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530220108950854e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0823434583.USD","LU0079474960.USD","LU1093756325.SGD","LU1551013342.USD","LU1929549753.HKD","LU0820561818.USD","IE00BKVL7J92.USD","LU1551013425.SGD","LU1674673691.USD","SG9999001440.SGD","LU0234572021.USD","BK4083","LU1035775433.USD","LU1914381329.SGD","LU1093756168.USD","BK4550","LU1674673428.USD","BK4585","LU0889565916.HKD","LU1069344957.HKD","LU1778281490.HKD","LU0823434740.USD","BK4566","IE00B1XK9C88.USD","PTCT","BK4533","LU0689472784.USD","BK4504","LU0320765646.SGD","IE00BSNM7G36.USD","LU0868494708.USD","LU2756315318.SGD","IE00BWXC8680.SGD","BK4567","LU1989772923.USD","BK4581","LU0820562030.AUD","LU0943347566.SGD","BK4588","HD","LU0320765992.SGD","LU0942090050.USD","LU1989772840.SGD","LU1162221912.USD","LU1496350502.SGD","QURE","LU1496350171.SGD","LU0354030438.USD","LU2756315664.SGD"],"gpt_icon":0},{"id":"2538495406","title":"Uniqure N.V.盘中异动 下午盘急速上涨5.08%报15.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538495406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538495406?lang=zh_cn&edition=full","pubTime":"2025-05-28 01:06","pubTimestamp":1748365569,"startTime":"0","endTime":"0","summary":"北京时间2025年05月28日01时06分，Uniqure N.V.股票出现异动，股价快速上涨5.08%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为1.33%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。消息层面，截至01时06分，《神经科医生看好亨廷顿病将上市疗法 瑞银力挺uniQure潜力》资讯为影响Uniqure N.V.的重要信息。瑞银对 PTC Therapeutics Inc和 uniQure NV均持乐观态度，给予买入评级。该行强调，亨廷顿病领域患者认知度高、治疗意愿强烈，对PTC和uniQure而言均存在巨大机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505280106109767690f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505280106109767690f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1674673691.USD","SG9999001440.SGD","BK4533","LU0868494708.USD","IE00BWXC8680.SGD","BK4083","BK4585","IE00B1XK9C88.USD","BK4550","IE00BSNM7G36.USD","LU1093756325.SGD","LU2756315664.SGD","LU0868494617.USD","LU1035775433.USD","IE00BZ1G4Q59.USD","QURE","LU0823411888.USD","LU1496350171.SGD","HD","LU1778281490.HKD","LU0889565916.HKD","LU0820562030.AUD","LU0823434740.USD","LU0354030511.USD","LU0109394709.USD","LU1674673428.USD","LU0320765992.SGD","PTCT","BK4504","LU0823434583.USD","LU1162221912.USD","LU0942090050.USD","BK4534","LU0820561818.USD","LU1093756168.USD","BK4588","LU1929549753.HKD","LU1989772923.USD","BK4581","LU0320765646.SGD","LU0079474960.USD","LU1551013342.USD","LU0943347566.SGD","LU0354030438.USD","BK4567","IE00BKVL7J92.USD","LU0820561909.HKD","BK4566","LU1069344957.HKD","LU1989772840.SGD"],"gpt_icon":0},{"id":"2538551614","title":"神经科医生看好亨廷顿病将上市疗法 瑞银力挺uniQure(QURE.US)、PTC(PTCT.US)潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2538551614","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538551614?lang=zh_cn&edition=full","pubTime":"2025-05-27 16:50","pubTimestamp":1748335833,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞银近日发布生物科技领域研报，神经科医生对uniQure公司的AMT-130和PTC Therapeutics/诺华制药公司的PTC-518在亨廷顿病治疗中的表现十分乐观，若数据积极且疗法明日即可使用，则计划为25%的患者开具AMT-130处方，为40%的患者开具PTC-518处方。医生认为PTC和uniQure的数据前景乐观，并期待PTC在第二季度、uniQure在第三季度更新数据时能展示持续疗效。行业机遇与挑战该行强调，亨廷顿病领域患者认知度高、治疗意愿强烈，对PTC和uniQure而言均存在巨大机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1298049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2506952410.USD","BK4585","LU1951198990.SGD","BK4554","LU1721428347.USD","LU2506952337.HKD","LU2362541273.HKD","LU2362541513.USD","BK4576","LU2477742899.HKD","LU0109394709.USD","LU0889565916.HKD","BK4023","QURE","BK4139","LU1951200564.SGD","LU0320765992.SGD","BK4588","LU2362540622.SGD","PTCT","PTC","LU1923623000.USD"],"gpt_icon":0},{"id":"2537647532","title":"Uniqure N.V.盘中异动 下午盘股价大涨5.30%报15.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537647532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537647532?lang=zh_cn&edition=full","pubTime":"2025-05-21 01:36","pubTimestamp":1747762618,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日01时36分，Uniqure N.V.股票出现异动，股价快速拉升5.30%。截至发稿，该股报15.49美元/股，成交量38.8463万股，换手率0.71%，振幅6.93%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.53%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521013658aa2c9462&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521013658aa2c9462&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","NRXS","BK4139","BK4082"],"gpt_icon":0},{"id":"2536463227","title":"Uniqure N.V.盘中异动 快速上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536463227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536463227?lang=zh_cn&edition=full","pubTime":"2025-05-20 03:39","pubTimestamp":1747683565,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日03时39分，Uniqure N.V.股票出现波动，股价大幅拉升5.18%。截至发稿，该股报14.41美元/股，成交量78.5647万股，换手率1.44%，振幅6.79%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.49%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520033925a4846dd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520033925a4846dd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"gpt_icon":0},{"id":"2536948675","title":"Uniqure N.V.2025财年第一财季实现净利润-43.64百万美元，同比增加33.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536948675","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536948675?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:00","pubTimestamp":1747584020,"startTime":"0","endTime":"0","summary":"5月19日，Uniqure N.V.公布财报，公告显示公司2025财年第一财季净利润为-43.64百万美元，同比增加33.50%；其中营业收入为1.57百万美元，同比减少81.51%，每股基本收益为-0.82美元。从资产负债表来看，Uniqure N.V.总负债5.72亿美元，其中短期债务3.70百万美元，资产负债比为1.06，流动比率为0.12。机构评级：截至2025年5月19日，当前有12家机构对Uniqure N.V.目标价做出预测，其中目标均价为35.50美元，其中最低目标价为13.00美元，最高目标价为70.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000035a6e3a6e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000035a6e3a6e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE"],"gpt_icon":0},{"id":"2535313491","title":"Uniqure N.V.盘中异动 股价大涨5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535313491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535313491?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:31","pubTimestamp":1747402267,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时31分，Uniqure N.V.股票出现波动，股价急速上涨5.66%。截至发稿，该股报14.00美元/股，成交量2.1044万股，换手率0.04%，振幅0.23%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.15%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213108975bd86e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213108975bd86e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2535020622","title":"Uniqure N.V.盘中异动 早盘快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535020622","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535020622?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:32","pubTimestamp":1747229543,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时32分，Uniqure N.V.股票出现波动，股价大幅上涨5.00%。截至发稿，该股报13.45美元/股，成交量2.6927万股，换手率0.05%，振幅3.43%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.12%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421322494f6c7e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421322494f6c7e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","QURE","SEPN"],"gpt_icon":0},{"id":"2534480216","title":"Uniqure N.V.盘中异动 快速上涨6.53%报13.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534480216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534480216?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:34","pubTimestamp":1746797699,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时34分，Uniqure N.V.股票出现波动，股价急速拉升6.53%。截至发稿，该股报13.05美元/股，成交量27.7546万股，换手率0.51%，振幅7.71%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.54%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509213459a4783dd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509213459a4783dd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2533136134","title":"Uniqure N.V.盘中异动 早盘股价大涨5.17%报10.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533136134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533136134?lang=zh_cn&edition=full","pubTime":"2025-05-08 21:45","pubTimestamp":1746711918,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时45分，Uniqure N.V.股票出现异动，股价大幅上涨5.17%。截至发稿，该股报10.58美元/股，成交量25.2704万股，换手率0.46%，振幅3.68%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为3.27%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821451897534c90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821451897534c90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2533093664","title":"Uniqure N.V.盘中异动 早盘急速下挫5.00%报10.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533093664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533093664?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:34","pubTimestamp":1746624846,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时34分，Uniqure N.V.股票出现波动，股价大幅跳水5.00%。截至发稿，该股报10.91美元/股，成交量20.2616万股，换手率0.37%，振幅6.18%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.07%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213416a4756ef0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213416a4756ef0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0},{"id":"2533064698","title":"生物科技股大幅波动 uniQure NV领跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2533064698","media":"iDoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533064698?lang=zh_cn&edition=full","pubTime":"2025-05-07 05:19","pubTimestamp":1746566343,"startTime":"0","endTime":"0","summary":"5月7日，生物科技板块出现显著波动。uniQure NV收跌27.75%，Lexeo Therapeutics下跌26.97%，Sarepta Therapeutics跌幅达26.56%，位列跌幅前三。此外，Replimune等多家公司跌幅在19.62%-25.17%之间。与此同时，神经分泌生物科学上涨8.36%，CorMedix更是大涨23.59%，表现亮眼。市场情绪或受行业动态及财务数据影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050705210994ee5abd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050705210994ee5abd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.uniqure.com","stockEarnings":[{"period":"1week","weight":0.041},{"period":"1month","weight":-0.0073},{"period":"3month","weight":0.1531},{"period":"6month","weight":0.0669},{"period":"1year","weight":0.9218},{"period":"ytd","weight":-0.1512}],"compareEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":0.0504},{"period":"3month","weight":0.1922},{"period":"6month","weight":0.0502},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.0708}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"uniQure N.V.作为私人有限责任公司于2012年1月9日依照荷兰相关法律条文成立。uniQure公司在基因疗法领域是领导者，同时研发了第一个也是迄今为止唯一一个得到欧盟监管认可的基因疗法产品。通过引导治疗性蛋白基因或者通过的表达，或者通过单一管理修复缺失蛋白的表达，基因疗法向有基因或获得性疾病的患者提供长期而且潜在有效的利益。公司的第一个产品，即阿利泼金（Glybera），由于该药对脂蛋白脂酶缺乏（LPLD）患者治疗的极佳效果被欧洲委员会在2012年10月通过，上述疾病是具有潜在生命危险的孤儿代谢性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":-0.00526},{"month":2,"riseRate":0.545455,"avgChangeRate":0.064233},{"month":3,"riseRate":0.25,"avgChangeRate":-0.054124},{"month":4,"riseRate":0.416667,"avgChangeRate":0.018299},{"month":5,"riseRate":0.666667,"avgChangeRate":0.042965},{"month":6,"riseRate":0.416667,"avgChangeRate":-0.009437},{"month":7,"riseRate":0.333333,"avgChangeRate":0.039455},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.009211},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.100177},{"month":10,"riseRate":0.454545,"avgChangeRate":0.051369},{"month":11,"riseRate":0.818182,"avgChangeRate":0.121162},{"month":12,"riseRate":0.272727,"avgChangeRate":0.14834}],"exchange":"NASDAQ","name":"uniQure N.V.","nameEN":"uniQure NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"uniQure N.V.(QURE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供uniQure N.V.(QURE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"uniQure N.V.,QURE,uniQure N.V.股票,uniQure N.V.股票老虎,uniQure N.V.股票老虎国际,uniQure N.V.行情,uniQure N.V.股票行情,uniQure N.V.股价,uniQure N.V.股市,uniQure N.V.股票价格,uniQure N.V.股票交易,uniQure N.V.股票购买,uniQure N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"uniQure N.V.(QURE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供uniQure N.V.(QURE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}